Antiangiogenic phenylpropanoid glycosides from Gynura cusimbua

Nat Prod Res. 2019 Feb;33(4):457-463. doi: 10.1080/14786419.2017.1389931. Epub 2017 Oct 20.

Abstract

A new phenylpropanoid glycoside, named α-L-rhamnopyranosyl-(1↔2)-β-D-[4″-(8E)-7-(3,4-dihydroxyphenyl)-8-propenoate, 1″-O-(7S)-7-(3,4-dihydroxyphenyl)-7-methoxy-ethyl]-glucopyranoside (1), together with nine known compounds (2-10) were isolated from the active fraction (n-Butanol fraction) of Gynura cusimbua for the first time. The known compounds (2-10) were identified as phenylpropanoid glycosides on the basis of extensive spectral data and references. The antiangiogenic activities of compounds (1-10) were evaluated by MTT assay on HUVECs and wild-type zebrafish in vivo model assay. As a result, compounds 1, 6, 7, 8 and 10 exhibited certain antiangiogenic activities.

Keywords: antiangiogenic activities; phenylpropanoid glycosides.

MeSH terms

  • Alkaline Phosphatase / metabolism
  • Angiogenesis Inhibitors / chemistry*
  • Angiogenesis Inhibitors / pharmacology*
  • Animals
  • Asteraceae / chemistry*
  • Cell Proliferation / drug effects
  • Drug Evaluation, Preclinical / methods
  • Embryo, Nonmammalian / blood supply
  • Embryo, Nonmammalian / drug effects
  • Glycosides / chemistry*
  • Glycosides / pharmacology*
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Magnetic Resonance Spectroscopy
  • Molecular Structure
  • Zebrafish / embryology

Substances

  • Angiogenesis Inhibitors
  • Glycosides
  • Alkaline Phosphatase